Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Interleukin 2 Treatment for HIV Infection

Article Abstract:

More research is needed before interleukin-2 (IL-2) treatment can be recommended to HIV patients. A study published in 2000 showed that HIV patients who received traditional AIDS drugs plus IL-2 had greater immune recovery than those who took AIDS drugs only. However, 54% of the patients taking AIDS drugs plus IL-2 developed side effects compared to only 16% of those taking AIDS drugs only. Researchers also need to determine whether the modest immune recovery has any health benefits. One study showed that patients with severe immunosuppression did not benefit from IL-2 treatment.

Author: Blankson, Joel, Siliciano, Robert F.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
Interleukin-2

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Initiating Antiretroviral Therapy During HIV Infection: Confusion and Clarity

Article Abstract:

Doctors may be able to avoid treating some HIV patients with AIDS drugs until the patient's CD4 T cell count drops to 200. Two studies published in 2001 show that patients with CD4 T cell counts of 200 or more will respond to treatment and have a low risk of progression to AIDS and death. Waiting to begin treatment can spare the patient from the severe side effects of many AIDS drugs.

Author: Pomerantz, Roger J.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
CD4 lymphocytes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Structured Treatment Interruptions for the Management of HIV Infection. (Special Communication)

Article Abstract:

HIV patients who are in the early stages of the infection may benefit from stopping treatment periodically. This will reduce the number of side effects they experience. However, more research is needed to determine whether sicker patients benefit from treatment interruptions.

Author: Lori, Franco, Lisziewicz, Julianna
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Editorial, HIV infection, Drug therapy, HIV infections
Similar abstracts:
  • Abstracts: The role of early HIV infection in the spread of HIV through populations. Mutation takes no vacation: can structured treatment interruptions increase the risk of drug-resistant HIV-1?
  • Abstracts: Specific transplantation tolerance. Photopheresis for the prevention of rejection in cardiac transplantation. Improving the success of organ transplantation
  • Abstracts: Body piercing: controlling the risk of infection. Risk factors for infection in nursing homes. Infection control liaison nurse training
  • Abstracts: Nutrition as part of treatment. The nutritional and nursing benefits of social mealtimes
  • Abstracts: Supervision for nurse specialists. Using structured reflection to improve nursing practice
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.